2026 Agenda
| Time | Session |
|---|---|
| 8:00 - 8:30 | Registration + Coffee |
| 8:30 - 8:40 |
Welcoming RemarksNima Sharifi, M.D. |
Session 1: Metabolic Interventions in Human Health and Disease |
|
| 8:40 - 9:30 |
Interventional Cardiac Metabolic PathophysiologyZoltan Pierre Arrany, M.D., Ph.D. |
| 9:30 - 10:00 |
Ketogenic Fasting Interventions in Prostate CancerLaura Sena, M.D., Ph.D. |
| 10:00 - 10:30 | Morning Break |
| 10:30 - 11:00 |
Fatty Acid Synthase Inhibition Clinical Studies in Prostate CancerMassimo Loda, M.D. |
| 11:00 - 11:30 |
Metabolic Health and Prostate Cancer SurvivorshipAlicia Morgans, M.D., M.P.H. |
| 11:30 - 1:00 | Lunch |
Session 2: Prostate Cancer Metabolism |
|
| 1:00 - 1:30 |
Androgen Production, Uptake, and Conversion Enzymes in CRPCCharles Ryan, M.D. |
| 1:30 - 2:00 |
Alternative Androgen Synthesis Pathways in Prostate CancerNima Sharifi, M.D. |
| 2:00 - 2:30 |
Pyruvate Kinase is a Therapeutic Target in Prostate CancerDaniel Schmidt, M.D., Ph.D. |
| 2:30 - 3:00 |
A Stress-Adaptive Lipid Kinase Axis Defines Metabolic Vulnerabilities in Neuroendocrine Prostate CancerYuanyuan Qiao, Ph.D. |
| 3:00 - 3:30 | Afternoon Break |
Session 3: Metabolic Mechanisms and Approaches |
|
| 3:30 - 4:00 |
Targeting Metabolism in Prostate CancerShaun Stauffer, Ph.D. |
| 4:00 - 4:30 |
Dark GPCRs and Mitochondrial TransportDaniel Isom, Ph.D. |
| 4:30 - 5:00 |
Ketone-body Dependent Post Translational ModificationsZhipeng Wang, Ph.D. |
| 5:00 |
Closing RemarksNima Sharifi, M.D. |
| 5:00 - 8:00 | Poster Session and Reception |
Past Agendas
-
2025
-
2024